Pfizer Inc may sweeten its offer for Britain's AstraZeneca Plc to more than 63 billion pounds, or $106 billion, and raise the cash portion of the deal, to kickstart negotiations, Bloomberg reported on Thursday. Citing people with knowledge of the matter, the report said a new bid may value AstraZeneca at more than 50 pounds per share and could come as early as next week. Pfizer disclosed earlier this week that it had twice approached AstraZeneca about a takeover, only to be rebuffed in both cases.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN traded higher by 2.45% or $1.9332/share to $80.98. In the past year, the shares have traded as low as $46.87 and as high as $79.90. On average, 3161930 shares of AZN exchange hands on a given day and today's volume is recorded at 8335320.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE fell by 0.48% or $-0.15/share to $31.13. In the past year, the shares have traded as low as $27.12 and as high as $32.96. On average, 29118400 shares of PFE exchange hands on a given day and today's volume is recorded at 22289060.
Source
